Pulmonx Corp — Director's Dealing 2025

Dec 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2025-12-01

Reporting Person: Sung Derrick (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-01	Common Stock	A	1200000	—	Acquired	1335319	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-12-01	Performance Stock Units	$	A	400000	Acquired	2028-12-01	Common Stock (400000)	Direct

Footnotes

F1: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer, 25% of which vests one year from the grant date of December 1, 2025, and the remainder vests in equal quarterly installments over the three-year period following the date of grant.

F2: Each Performance Stock Unit represents a contingent right to receive one share of the Issuer's common stock. The Performance Stock Units vest upon meeting the following two conditions: (a) upon the Issuer's common stock achieving a specified price per share and (b) with respect to 33% on the one year following the grant date of December 1, 2025 and the remainder in eight equal quarterly installments.